Home > > Asia And Global Gene Therapy Market- Size, Share, Growth Rate, and Forecast
The Asia Gene Therapy market was valued at $489.2 Million in 2023, and is projected to reach $1,445.5 Million by 2030 growing at a CAGR of 16.82% from 2024 to 2030. Non-Viral Vectors segment is expected to be the highest contributor to this market, with $416.2 Million in 2023, and is anticipated to reach $1,018.2 by 2030, registering a CAGR of 13.68%. Viral Vectors segment is anticipated to reach $427.3 Million by 2030 with the highest CAGR of 28.09%. Vector Non-Viral Vectors Viral Vectors Indication Neurological Diseases Cancer Hepatological Diseases Duchenne Muscular Dystrophy Other Indications Delivery Method In-Vivo Gene Theraoy Ex-Vivo Gene Theraoy BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China RoAPAC Middle East & Africa Latin America MEA